Lmr Partners LLP Vincerx Pharma, Inc. Transaction History

Lmr Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.66 - $1.38 $32,273 - $67,480	-48,899 Reduced 83.02%	10,000 $10,000
Q2 2023 Aug 14, 2023	SELL	$0.88 - $1.9 $968 - $2,091	-1,101 Reduced 1.84%	58,899 $76,000
Q4 2022 Feb 14, 2023	SELL	$0.64 - $1.32 $1,875 - $3,867	-2,930 Reduced 4.66%	60,000 $61,000
Q2 2022 Aug 15, 2022	BUY	$0.0 - $0.0 $0 - $0	11,730 Added 22.91%	62,930 $83,000
Q1 2022 May 16, 2022	BUY	$0.0 - $0.0 $0 - $0	51,200 New	51,200 $205,000

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.